Factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: a 2-year longitudinal study.
about
Accelerated atherosclerosis in patients with SLE--mechanisms and managementRisk factors in the progression of subclinical atherosclerosis in women with systemic lupus erythematosus.A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus.Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus.Cardiovascular risk in pediatric-onset rheumatological diseases.Complement activation: an emerging player in the pathogenesis of cardiovascular diseaseInflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin.Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.Pathogenesis and treatment of atherosclerosis in lupus.Why are kids with lupus at an increased risk of cardiovascular disease?Association between ischemic heart disease and systemic lupus erythematosus-a large case-control study.Anti-apolipoprotein A-1 antibodies and carotid intima-media thickness in Egyptian women with systemic lupus erythematosus.Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study.Complement anaphylatoxin C4a inhibits C5a-induced neointima formation following arterial injury.Premature coronary heart disease in SLE: can we prevent progression?Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis.Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis.Carotid subclinical atherosclerosis is associated with disease activity but not vitamin D in Korean systemic lupus erythematosus.
P2860
Q26820245-8FB8624C-64B1-4E14-BD22-7F74A40841F4Q33800900-358AFBB4-4C7D-4A18-8FB5-7D5AEC5E6356Q33931813-C64911A5-ECFC-4199-8E56-DAD219D57DA4Q35639129-34ECA3D4-3B91-4710-AA20-2BA9E5C420C9Q36903089-289E0621-CE7D-493A-A89E-A34539518271Q37288362-EBC5798F-48C6-4FA5-BAA0-200085CA0F89Q37782589-F220E53B-B327-42AA-8F1A-205596652006Q38162490-B3340317-1077-4462-A27B-4B89AD369371Q38230699-CFE68361-968F-435F-8D40-F51B572E717FQ38591752-2EA4BCB5-158D-47E2-9AE5-CCC26F1B165DQ39017583-0E80299B-2423-4148-808C-E2A9BD72F3DBQ39377043-3200E2EB-805E-4B19-B3E1-287C5913049EQ40562190-CAB04AA0-9160-47D5-AFBC-1D072989B47BQ41087929-A1D951EC-058E-4CAA-A592-6899A273379DQ43900414-9FA7ADA7-4B86-4C2B-B017-4DD7AB4E9E9EQ50052184-93DFAF74-8CE6-42F7-AC97-DC71517786E1Q50950582-FE453466-102B-48D2-A198-9C6BF63D300FQ51125181-FC575616-4A5E-4563-B3B6-4536D8C38CF2
P2860
Factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: a 2-year longitudinal study.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Factors involved in the progre ...... : a 2-year longitudinal study.
@ast
Factors involved in the progre ...... : a 2-year longitudinal study.
@en
type
label
Factors involved in the progre ...... : a 2-year longitudinal study.
@ast
Factors involved in the progre ...... : a 2-year longitudinal study.
@en
prefLabel
Factors involved in the progre ...... : a 2-year longitudinal study.
@ast
Factors involved in the progre ...... : a 2-year longitudinal study.
@en
P2093
P356
P1476
Factors involved in the progre ...... : a 2-year longitudinal study.
@en
P2093
C Erausquin
C Rodríguez-Gallego
C Rodríguez-Lozano
F Francisco
I Garcia-Laorden
I Rua-Figueroa
J Rodríguez-Perez
O Arencibia-Mireles
P304
P356
10.1136/ARD.2008.104349
P407
P577
2009-08-16T00:00:00Z